Agenda Profile: Riina Solman
Draft law amending the Medicinal Products Act and the Act on the Organisation of Health Care Services (458 SE) – Second Reading
2024-10-24
15th Riigikogu, 4th sitting, plenary session
Political Position
The political stance heavily emphasizes the transparency of the legislative process and the necessity of public clarification, particularly when decisions are made late in the session. The speaker is demanding answers concerning the transfer of medication lists from the Health Board to the jurisdiction of hospitals, specifically inquiring about the precise substance and rationale behind this change. While the bill itself, when examined in isolation, is not objectionable, the primary focus remains on the details and the need for public debate, underscoring a policy-driven approach.
2 Speeches Analyzed
Topic Expertise
The speaker demonstrates knowledge in the field of healthcare administration and pharmaceutical logistics, particularly concerning the movement of drug lists between the Health Board and regional hospitals. Specific terminology, such as "wholesale firms" and "the Health Board," is used, emphasizing the potential economic impact of the changes. The expertise is focused on highlighting organizational and economic details.
2 Speeches Analyzed
Rhetorical Style
The rhetorical style is demanding and procedural, expressing dissatisfaction with the rapporteur's refusal to publicly answer a "perfectly logical question." The speaker emphasizes the necessity of public discussion ("in the public eye") and employs a logical appeal to ensure that the answers are recorded in the transcript and reach the readers. The tone is formal, addressing the esteemed Vice-Chairman and the rapporteur.
2 Speeches Analyzed
Activity Patterns
The pattern of activity demonstrates active participation in the Riigikogu's plenary sessions, even late at night, with a focus on submitting questions and criticizing procedural deficiencies. The speaker aims to ensure that important debates and answers take place publicly, rather than being confined solely to committee proceedings.
2 Speeches Analyzed
Opposition Stance
The opposition is aimed at the rapporteur (Eero Merilind) and the committee's procedure, both of whom refused to answer publicly, citing only internal committee discussions. The criticism is twofold: procedural, demanding public answers, and substantive, questioning the rationale for the change and its economic impact on wholesale firms.
2 Speeches Analyzed
Collaboration Style
The current style of cooperation is confrontational, as the speaker is criticizing the presenter's refusal to answer publicly and is demanding answers. There is absolutely no reference to collaboration, seeking compromise, or bilateral support; the focus is entirely on demanding accountability.
2 Speeches Analyzed
Regional Focus
The focus is on organizing healthcare at the national level, referencing the Health Board and "regional hospitals" within the context of pharmaceutical logistics. There is no specific emphasis placed on a particular local region or electoral district; instead, the national administrative structure is being addressed.
2 Speeches Analyzed
Economic Views
Economic perspectives are driven by concerns over the potential revenue loss for wholesale firms resulting from the shifting of pharmaceutical lists. This points to a sensitivity regarding the impact of regulatory changes on private sector business interests and the potential for market anxiety.
2 Speeches Analyzed
Social Issues
Social issues directly concern the organization of healthcare and pharmaceutical logistics, which is a broader social topic. The speeches do not address other social topics such as education, immigration, or civil liberties.
2 Speeches Analyzed
Legislative Focus
The legislative focus is currently on the draft legislation (Bill 458 SE) amending the Medicinal Products Act and the Health Services Organisation Act, which is undergoing its second reading. The speaker is a critical questioner demanding clarification regarding the restructuring of the management of the medicinal products list and its consequences.
2 Speeches Analyzed